Navigation Links
NIH neuroscience microarray consortium launches high-throughput genotyping services

The NIH Neuroscience Microarray Consortium today announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services. Stan Nelson, the principal investigator at UCLA, says that "adding ultra-high throughput genotyping for its user-base of ~10,000 investigators across the world keeps the Consortium current with the demands of the scientific community."

The Consortium is comprised of four nationally recognized centers located at Duke University in Durham, NC, the Translational Genomics Research Institute (TGen) in Phoenix, AZ, the University of California in Los Angeles, and Yale University in New Haven, CT. The Consortium can be accessed through its web portal at http://arrayconsortium.tgen.org.

Initially funded in 2002 by the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH), the Microarray Consortium is now supported by these two institutes as well as the thirteen other NIH Neuroscience Blueprint institutes and centers.

"The consortium that we have established over the past four years is a nation-wide technology outlet that dramatically accelerates the pace of neuroscience research," said Consortium Chairman Dr. Dietrich Stephan, who is also the director of TGen's Neurogenomics Division. "Implementing these high throughput genotyping services will ultimately make a dramatic impact in clinical care of neurological disorders."

About 10,000 investigators funded through the 15 different NIH institutes are part of the NIH Neuroscience Blueprint and have access to the technology and expertise within the national Consortium. "Now," says Pate Skene, the PI at Duke University, "scientists investigating any aspect of the brain, behavior or neurological disease have access to a full range of microarray technologies for scanning the entire human genome and all of the genes f or which it encodes."

Each of the four members of the Consortium offer specialized services. The Translational Genomics Research Institute (TGen) offers both expression profiling and SNP genotyping on Affymetrix Genechips. UCLA, in addition to the Affymetrix platform, processes Agilent arrays; Duke offers LCM services, Ambion mirVana arrays, and Operon oligo arrays; Yale offers expression profiling and genotyping on the Affymetrix platform and uses the Affymetrix exon arrays to look at splice variants, in addition to the new Illumina expression and genotyping capabilities.

The principal investigator at Yale, Shrikant Mane, says that the "Illumina platform provides an important complement to the other technologies currently available through the NIH Neuroscience Microarray Consortium and will significantly aid the research goals of the neuroscientist."


'"/>

Source:The Translational Genomics Research Institute


Related biology news :

1. An entropy-based gene selection method for cancer classification using microarray data
2. Genrate: a generative model that finds and scores new genes and exons in genomic microarray data
3. Different microarray systems more alike than previously thought
4. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
5. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
6. Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool
7. Chromosomal microarray analysis proves accurate
8. International HapMap consortium expands mapping effort
9. Autism gene identified by researchers at Yale working with a global research consortium
10. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
11. UNC launches study of liver injury caused by drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/30/2019)... ... October 29, 2019 , ... ... kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa & 704sa. The kits, in ... UA, UTP, and UUN. , Each VALIDATE® kit, liquid, ready-to-use, and prepared using ...
(Date:10/30/2019)... BALTIMORE, Md. (PRWEB) , ... October 30, 2019 ... ... at the 12th Annual CBRNe Convergence in Nashville, TN from Tuesday, November 5, ... and military responses to CBRNe (chemical, biological, radiological, nuclear) and IED (explosive) threats. ...
(Date:10/30/2019)... ... October 30, 2019 , ... ... exhibit self-assembly properties and bioactivity that are encoded by the ordering of ... peptides in the shift of the sidechain attachment to the backbone amide-nitrogen ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... November 04, 2019 , ... ... development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health ... GPEx® Boost. The technology enhances Catalent’s proven GPEx expression platform through multiple ...
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical trial usually ... other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so ... of the latest data, potentially leading to patient risk. , By having a ...
(Date:10/30/2019)... ... October 30, 2019 , ... While using cold plasma to kill cancer ... South Dakota School of Mines & Technology are exploring new ways to regulate ... , If successful, the technique would prove to be a drug-free, minimally invasive ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, ... and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November ... , The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology ...
Breaking Biology Technology: